The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Cullinan Therapeutics, Inc. has a cash-rich balance sheet and no financial debt while trading at a reasonable valuation. Read ...

The CHF11.12 analyst price target for CLN is 8.2% less than our estimate of fair value Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Clariant AG (VTX ...

Cullinan Oncology’s CLN-081 today received a Breakthrough Therapy Designation from the FDA for the treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC). Cullinan Oncology’s ...

Cullinan Therapeutics focuses on unaddressed or unmet needs in oncology and autoimmune conditions. In particular, Zipalertinib and CLN-978 stand out as its most promising product candidates.

Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough therapy designation to CLN-081 for treatment of certain patients with non-small ...

Designed for individuals with oily or problem-prone skin, ProStrength supports a healthier-looking appearance with consistent use, without damaging the skin barrier. Developed for those seeking ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Stellantis is taking steps to save one of its key suppliers according to a number of media reports. CLN-Coils Lamiere Nastri SpA (CLN) supplies a range of steel-based automotive components to ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.